MicroRNA Expression Profiling of Human-Induced Pluripotent and Embryonic Stem Cells

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 936)

Abstract

Clinical implications of induced pluripotent stem (iPS) cell technology are enormous for personalized medicine. However, extensive use of viral approach for ectopic expression of reprogramming factors is a major hurdle in realization of its true potential. Non-viral methods for making iPS cells, although plausible, are impractical because of high cost. MicroRNAs are important cellular modulators that have been shown to rival transcription factors and are important players in embryonic development. We have generated distinct “microRNA-omes” signature of iPS cells that remain in a near embryonic stem (ES) cell state and distinct from differentiated cells. Recent advances in the microRNA field and experimentally validated microRNAs warrant a review in experimental protocols for microRNA expression profile.

Key words

ES cells iPS cells MicroRNA Microarray 

References

  1. 1.
    Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676PubMedCrossRefGoogle Scholar
  2. 2.
    Yu J et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920PubMedCrossRefGoogle Scholar
  3. 3.
    Ghosh Z, Huang M, Hu S, Wilson KD, Dey D, Wu JC (2011) Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res 71(14):5030–5039PubMedCrossRefGoogle Scholar
  4. 4.
    Warren L et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618–630PubMedCrossRefGoogle Scholar
  5. 5.
    Patel M, Yang S (2010) Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev 6(3):367–380PubMedCrossRefGoogle Scholar
  6. 6.
    Papp B, Plath K (2011) Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res 21(3):486–501PubMedCrossRefGoogle Scholar
  7. 7.
    Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132(21):4653–4662PubMedCrossRefGoogle Scholar
  8. 8.
    Guo H et al (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835–840PubMedCrossRefGoogle Scholar
  9. 9.
    Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12(2):99–110PubMedCrossRefGoogle Scholar
  10. 10.
    Mallanna SK, Rizzino A (2010) Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev Biol 344(1):16–25PubMedCrossRefGoogle Scholar
  11. 11.
    Wilson KD et al (2009) MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 18(5):749–758PubMedCrossRefGoogle Scholar
  12. 12.
    Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ, Baugh JJ, Jia F, Ghosh Z, Li RA, Butte AJ, Wu JC (2010) Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 3(5):426–435PubMedCrossRefGoogle Scholar
  13. 13.
    Stadler B et al (2010) Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 19(7):935–950PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Department of Medicine, Division of Cardiology and Institute of Stem Cell Biology and Regenerative MedicineStanford University School of MedicineStanfordUSA
  2. 2.Department of Medicine, Division of CardiologyStanford University School of MedicineStanfordUSA

Personalised recommendations